<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-26T10:42:09Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/7403" metadataPrefix="qdc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/7403</identifier><datestamp>2023-08-26T12:58:36Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Virological Correlates of IgM–IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens</dc:title>
   <dc:creator>Barreiro, Pablo</dc:creator>
   <dc:creator>Candel González, Francisco Javier</dc:creator>
   <dc:creator>Sanz, Juan Carlos</dc:creator>
   <dc:creator>San Román Montero, Jesús</dc:creator>
   <dc:creator>del Mar Carretero, María</dc:creator>
   <dc:creator>Pérez Abeledo, Marta</dc:creator>
   <dc:creator>Ramos, Belén</dc:creator>
   <dc:creator>Viñuela Prieto, José Manuel</dc:creator>
   <dc:creator>Canora, Jesús</dc:creator>
   <dc:creator>Martínez Peromingo, Francisco Javier</dc:creator>
   <dc:creator>Zapatero, Antonio</dc:creator>
   <dcterms:abstract>The virological meaning of the different patterns of serology in COVID-19 has been little examined in clinical settings. Asymptomatic subjects with IgM-spike (S) and IgG-nucleocapsid (N) determinations by chemiluminescence were studied for SARS-CoV-2 shedding in respiratory secretions by transcription-mediated amplification (TMA). In subjects showing IgM-S positive and IgG-N negative, IgG-S was determined by lateral flow assay. A total of 712 individuals were tested: 30.0% presented IgM-S(+)/IgG-N(−), 25.8% had IgM-S(+)/IgG-N(+) and 44.2% had IgM-S(−)/IgG-N(+); the proportion with TMA(+) were comparable in these three groups: 12.1, 8.7 and 10.5%, respectively. In individuals with IgM-S(+)/IgG-N(−), IgG-S(+) was detected in 66.5%. The frequency of IgM-S(+)/IgG-S(−) in the total population was 10.0%, of whom 24.1% had TMA(+); the chances for TMA(+) in subjects with an IgM-S(+) alone pattern were 2.4%. Targeting of the same SARS-CoV-2 antigen seems to be better for the characterization of IgM/IgG patterns of response. IgM-S(+) alone reactivity is rare, and a small proportion is associated with viral shedding.</dcterms:abstract>
   <dcterms:dateAccepted>2023-06-17T08:32:34Z</dcterms:dateAccepted>
   <dcterms:available>2023-06-17T08:32:34Z</dcterms:available>
   <dcterms:created>2023-06-17T08:32:34Z</dcterms:created>
   <dcterms:issued>2021-05-10</dcterms:issued>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/7403</dc:identifier>
   <dc:identifier>1999-4915</dc:identifier>
   <dc:identifier>10.3390/v13050874</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>https://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:rights>Atribución 3.0 España</dc:rights>
   <dc:publisher>MDPI</dc:publisher>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>